V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006043 | 330002864 | 1.76 | 68 | Curative (C) | null | 2014-09-23 | Cisplatin+Doxorubicin+Etoposide 28d | null | null | 330016353 | UKALL2014 |
| 330006044 | 330002865 | null | 51.9 | Curative (C) | 2016-02-10 | 2016-02-19 | Cisplatin + Docetaxel | N | N | 330016354 | PACLITAXEL |
| 330006045 | 330002866 | 1.93 | 61.7 | Palliative (P) | 2014-01-05 | 2014-01-05 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 330016377 | VINBLASTINE |
| 330006046 | 330002867 | 0 | 105.05 | Curative (C) | 2014-06-12 | 2014-06-12 | CNS HGG HERBY Temozolomide+XRT | 02 | N | 330016409 | HYDROXYCARBAMIDE |
| 330006047 | 330002867 | null | null | Palliative (P) | 2016-05-10 | 2016-05-10 | Sunitinib | Y | N | 330016409 | TEMOZOLOMIDE + RT |
| 330006048 | 330002867 | null | null | Adjuvant (A) | 2013-05-20 | 2013-06-29 | ALL UKALL2011 Ind A Sht Dex (PAsp) | N | N | 330016409 | CAPECITABINE + IRINOTECAN |
| 330006049 | 330011530 | 1.63 | null | null | 2014-07-01 | 2014-07-02 | Methotrexate High Dose (3g/m2) | 02 | N | 330016548 | AZACITIDINE |
| 330006050 | 330011530 | null | 81.8 | Curative (C) | null | 2014-12-21 | Azacitidine | null | null | 330016548 | UKALL 2011 |
| 330006051 | 330011530 | null | 50.9 | Disease modification (D) | 2014-05-14 | 2014-06-09 | Mitotane 4 - 4.5g | N | N | 330016548 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330006052 | 330002868 | 1.6 | 89.7 | Adjuvant (A) | 2016-01-05 | 2016-01-13 | Paclitaxel (2 or 3 weekly) | null | null | 330016774 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330006053 | 330002869 | 1.68 | 93 | Neo-adjuvant (N) | 2014-05-06 | 2014-05-23 | Doxorubicin + Ifosfamide | 2 | N | 330016794 | AML17 TRIAL |
| 330006054 | 330002870 | 1.67 | 65 | Neo-adjuvant (N) | 2017-01-29 | 2017-02-22 | Cisplatin + Vinorelbine (IV) | N | N | 330016933 | VINBLASTINE |
| 330006055 | 330002870 | 1.75 | 92.15 | Adjuvant (A) | 2016-06-10 | 2016-06-12 | Chlorambucil | N | null | 330016933 | BEP |
| 330006056 | 330002870 | null | null | Curative (C) | 2017-10-18 | 2017-10-21 | FLAG + Idarubicin | Y | N | 330016933 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330006057 | 330002871 | 1.62 | 62.5 | Palliative (P) | 2017-02-06 | 2017-02-06 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 330017182 | CARBOPLATIN + VINCRISTINE |
| 330006058 | 330002871 | null | null | Neo-adjuvant (N) | 2016-06-06 | 2016-06-21 | CNS Low Grade Glioma Vinblastine | N | Y | 330017182 | BORTEZOMIB + PANOBINOSTAT |
| 330006059 | 330002871 | 1.74 | 71.6 | Neo-adjuvant (N) | 2017-06-11 | 2017-06-14 | AML 18 TRIAL | 2 | N | 330017182 | MITOTANE |
| 330006060 | 330002872 | 1.75 | 63.3 | Curative (C) | 2018-09-13 | 2018-09-21 | Hydroxycarbamide | N | N | 330018089 | TEMOZOLOMIDE + RT |
| 330006061 | 330002873 | 1.93 | null | null | null | 2013-12-21 | FLAG + Idarubicin | null | null | 330018108 | TCF |
| 330006062 | 330007550 | null | 84.4 | Palliative (P) | 2015-08-30 | 2015-09-04 | Carboplatin + Pemetrexed | N | N | 330018177 | UKALL60+ |
| 330006063 | 330002874 | 1.74 | 52 | Adjuvant (A) | 2015-12-05 | 2015-12-06 | IPILIMUMAB + NIVOLUMAB | 2 | N | 330018246 | TEMOZOLOMIDE |
| 330006064 | 330002875 | 1.53 | 87.35 | Curative (C) | 2016-06-08 | 2016-06-22 | GEMCITABINE | N | Y | 330018430 | VIDE |
| 330006065 | 330002876 | 1.83 | 60 | Palliative (P) | 2017-11-17 | 2017-11-24 | VIDE | 2 | N | 330018482 | CARBOPLATIN + CETUXIMAB + FU |
| 330006066 | 330002876 | null | null | Disease modification (D) | 2017-06-04 | 2017-06-04 | CAELYX + CYCLOPHOSPHAMIDE + VINCRISTINE | Y | N | 330018482 | AZACITIDINE |
| 330006067 | 330002876 | 1.61 | 84.5 | Curative (C) | 2014-10-25 | 2014-11-07 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 330018482 | CARBOPLATIN + DOXORUBICIN |
| 330006068 | 330002877 | 1.69 | 102.5 | null | 2018-02-17 | 2018-02-24 | Dacarbazine | N | N | 330018870 | CYTARABINE |
| 330006069 | 330002878 | 1.79 | 76 | Curative (C) | 2015-08-09 | 2015-08-09 | Cisplatin + Vinorelbine (PO) | N | N | 330018947 | BEVACIZUMAB |
| 330006070 | 330002879 | null | 67 | Curative (C) | 2016-06-20 | 2016-06-25 | Etoposide + Ifosfamide (3 days) | 02 | N | 330019029 | VINBLASTINE |
| 330006071 | 330002879 | 1.64 | 52.7 | Curative (C) | 2017-09-12 | 2017-10-09 | R Chlorambucil | 2 | N | 330019029 | ECX |
| 330006072 | 330002880 | 1.04 | null | Palliative (P) | 2018-08-17 | 2018-08-23 | CARBOPLATIN + RT | N | N | 330019201 | CAV |
| 330006073 | 330002881 | 0 | 67.8 | Curative (C) | 2015-01-18 | 2015-01-18 | Cisplatin+Doxorubicin+Etoposide 21d | N | N | 330019649 | CYTARABINE |
| 330006074 | 330002882 | null | null | null | 2015-04-22 | 2015-04-26 | Chlorambucil + Pred + Rituximab | N | Y | 330019709 | SUNITINIB |
| 330006075 | 330002883 | 1.71 | 70 | Curative (C) | 2017-11-17 | 2017-11-27 | Cytarabine Low Dose | N | N | 330019806 | VINBLASTINE |
| 330006076 | 330002883 | null | 55 | Palliative (P) | 2018-11-17 | 2018-11-20 | CARBOPLATIN + RT | N | null | 330019806 | CAPECITABINE + MITOMYCIN |
| 330006077 | 330002883 | null | 55.7 | Palliative (P) | 2016-02-10 | 2016-02-22 | Methotrexate + Folinic acid | 02 | N | 330019806 | GEMCITABINE |
| 330006078 | 330002884 | null | 61.7 | Curative (C) | 2018-07-09 | 2018-07-14 | VIDE | N | N | 330020297 | EPIRUBICIN |
| 330006079 | 330002885 | 1.8 | 86.3 | Palliative (P) | 2017-06-23 | 2017-08-18 | POMB/ACE | 02 | N | 330020339 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 330006080 | 330002886 | 1.69 | 86.9 | Curative (C) | 2017-11-24 | 2017-11-24 | VIDE | N | N | 330020434 | PEMBROLIZUMAB |
| 330006081 | 330002887 | null | 71 | null | 2017-07-26 | 2017-08-04 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 330020488 | VINBLASTINE |
| 330006082 | 330002887 | 1.06 | 66.9 | Palliative (P) | 2017-11-19 | 2017-11-20 | BLEOMYCIN | 02 | N | 330020488 | RUXOLITINIB |
| 330006083 | 330002888 | null | 66.4 | null | 2015-04-29 | 2015-04-29 | FLUOROURACIL + MITOMYCIN + RT | N | N | 330020496 | LIPOSOMAL DAUNORUBICIN |
| 330006084 | 330007555 | null | 67.1 | null | 2014-06-10 | 2014-06-10 | ALL UKALL2011 Ind A Sht Dex (PAsp) | null | N | 330020553 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330006085 | 330007555 | 0 | 79.5 | Curative (C) | 2013-04-18 | 2013-04-24 | CHOP R - 21 days | 2 | N | 330020553 | CHLORAMBUCIL |
| 330006086 | 330011531 | 1.83 | 56 | Palliative (P) | 2016-08-05 | 2016-08-09 | TEMOZOLOMIDE | 02 | N | 330020661 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 330006087 | 330002889 | 156.4 | 55.7 | Palliative (P) | 2016-08-02 | 2017-01-31 | Dacarbazine | N | N | 330020699 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 330006088 | 330002890 | 1.71 | 62.5 | Curative (C) | null | 2016-10-20 | VIDE | N | N | 330020701 | METHOTREXATE |
| 330006089 | 330002891 | 1.72 | 82.3 | Palliative (P) | 2016-08-22 | 2016-09-20 | Docetaxel + Gemcitabine with GCSF | N | N | 330020704 | CISPLATIN + DOXORUBICIN + ETOPOSIDE |
| 330006090 | 330002891 | null | 77.95 | Palliative (P) | null | 2017-09-27 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | null | null | 330020704 | CYCLOPHOSPHAMIDE + VINCRISTINE + LIPOSOMAL DOXORUBICIN |
| 330006091 | 330002892 | 1.64 | 71.4 | Disease modification (D) | 2018-11-05 | 2018-11-09 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | N | 330020777 | RAVVA TRIAL |
| 330006092 | 330002893 | 0 | null | Curative (C) | 2017-01-25 | 2017-01-26 | Mitotane 2g | 02 | N | 330020797 | DOCETAXEL + GEMCITABINE |